
### [MONDO:0016397](http://purl.obolibrary.org/obo/MONDO_0016397)
**Label:** lysosomal disease with epilepsy

**Subclasses:** [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720) (GM2 gangliosidosis), [MONDO:0009591](http://purl.obolibrary.org/obo/MONDO_0009591) (metachromatic leukodystrophy, juvenile form), [MONDO:0015674](http://purl.obolibrary.org/obo/MONDO_0015674) (late infantile neuronal ceroid lipofuscinosis), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0019366](http://purl.obolibrary.org/obo/MONDO_0019366) (Free sialic acid storage disease), [MONDO:0018299](http://purl.obolibrary.org/obo/MONDO_0018299) (sphingolipidosis with epilepsy), [MONDO:0012221](http://purl.obolibrary.org/obo/MONDO_0012221) (alpha-N-acetylgalactosaminidase deficiency type 1), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0009499](http://purl.obolibrary.org/obo/MONDO_0009499) (Krabbe disease), [MONDO:0016295](http://purl.obolibrary.org/obo/MONDO_0016295) (neuronal ceroid lipofuscinosis), [MONDO:0019261](http://purl.obolibrary.org/obo/MONDO_0019261) (infantile neuronal ceroid lipofuscinosis), [MONDO:0019262](http://purl.obolibrary.org/obo/MONDO_0019262) (juvenile neuronal ceroid lipofuscinosis), [MONDO:0019260](http://purl.obolibrary.org/obo/MONDO_0019260) (adult neuronal ceroid lipofuscinosis), [MONDO:0017719](http://purl.obolibrary.org/obo/MONDO_0017719) (gangliosidosis), [MONDO:0018937](http://purl.obolibrary.org/obo/MONDO_0018937) (mucopolysaccharidosis III), [MONDO:0017779](http://purl.obolibrary.org/obo/MONDO_0017779) (alpha-N-acetylgalactosaminidase deficiency), [MONDO:0018868](http://purl.obolibrary.org/obo/MONDO_0018868) (metachromatic leukodystrophy), [MONDO:0010028](http://purl.obolibrary.org/obo/MONDO_0010028) (sialuria), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), 

**Corr. equiv. classes:** [OMIM:272800](http://purl.obolibrary.org/obo/OMIM_272800), [Orphanet:487](http://www.orpha.net/ORDO/Orphanet_487), [Orphanet:309263](http://www.orpha.net/ORDO/Orphanet_309263), [Orphanet:581](http://www.orpha.net/ORDO/Orphanet_581), [Orphanet:309144](http://www.orpha.net/ORDO/Orphanet_309144), [OMIM:268800](http://purl.obolibrary.org/obo/OMIM_268800), [OMIM:245200](http://purl.obolibrary.org/obo/OMIM_245200), [Orphanet:834](http://www.orpha.net/ORDO/Orphanet_834), [OMIM:250100](http://purl.obolibrary.org/obo/OMIM_250100), [Orphanet:796](http://www.orpha.net/ORDO/Orphanet_796), [Orphanet:216](http://www.orpha.net/ORDO/Orphanet_216), [Orphanet:3137](http://www.orpha.net/ORDO/Orphanet_3137), [Orphanet:79279](http://www.orpha.net/ORDO/Orphanet_79279), [Orphanet:512](http://www.orpha.net/ORDO/Orphanet_512), [Orphanet:168491](http://www.orpha.net/ORDO/Orphanet_168491), [Orphanet:354](http://www.orpha.net/ORDO/Orphanet_354), [Orphanet:309152](http://www.orpha.net/ORDO/Orphanet_309152), [OMIM:269921](http://purl.obolibrary.org/obo/OMIM_269921), [Orphanet:845](http://www.orpha.net/ORDO/Orphanet_845), [Orphanet:79262](http://www.orpha.net/ORDO/Orphanet_79262), [Orphanet:79263](http://www.orpha.net/ORDO/Orphanet_79263), [Orphanet:646](http://www.orpha.net/ORDO/Orphanet_646), [Orphanet:371442](http://www.orpha.net/ORDO/Orphanet_371442), [Orphanet:79264](http://www.orpha.net/ORDO/Orphanet_79264), [Orphanet:3166](http://www.orpha.net/ORDO/Orphanet_3166), [OMIM:609241](http://purl.obolibrary.org/obo/OMIM_609241), 

**Class expressions from DL-Learner:**

- [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) 51.65%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 50.42%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0004329](http://purl.obolibrary.org/obo/HP_0004329) (Abnormality of the posterior segment of the globe) 50.15%
- [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) 50.15%
- [HP:0000618](http://purl.obolibrary.org/obo/HP_0000618) (Blindness) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 50.15%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) 50.15%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0004329](http://purl.obolibrary.org/obo/HP_0004329) (Abnormality of the posterior segment of the globe) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) 48.82%
- [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) 48.82%
- [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) 48.82%
- [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0001317](http://purl.obolibrary.org/obo/HP_0001317) (Abnormality of the cerebellum) 48.82%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0004329](http://purl.obolibrary.org/obo/HP_0004329) (Abnormality of the posterior segment of the globe) 48.82%
- [HP:0000479](http://purl.obolibrary.org/obo/HP_0000479) (Abnormal retinal morphology) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 48.82%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 48.76%
- Thing 48.75%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 48.75%


